GLIMP MP1

Product Description

GLIMP MP 1/500/15MG TABLET is indicated for the control of type II diabetes mellitus in instances where lifestyle modifications such as dietary changes and physical activity, along with monotherapy, fail to maintain optimal blood sugar levels. This medication is a combination of three active ingredients: Glimepiride, Metformin, and Pioglitazone, which are classified as antidiabetic agents. Prior to initiating treatment with GLIMP MP 1/500/15MG TABLET, it is essential to inform your healthcare provider about any pre-existing liver, kidney, or cardiovascular conditions. Additionally, you must disclose any history of eye disorders, hormonal imbalances, alcohol dependence, or nutritional deficiencies, including malnutrition or irregular eating habits. This medication is contraindicated in individuals diagnosed with type I diabetes mellitus, bladder cancer, severe heart failure, or lactic acidosis. To optimize the effectiveness of this treatment, patients should adhere to dietary recommendations and lifestyle adjustments as directed by their healthcare professional. It is advisable to refrain from smoking and consuming alcoholic beverages while on this medication, as these actions may worsen your condition. The most frequently reported adverse effects of GLIMP MP 1/500/15MG TABLET include episodes of low blood sugar, gastrointestinal discomfort such as nausea and constipation, sore throat, muscle soreness, headaches, dizziness, and potential weight gain. If any of these symptoms become more severe, seek medical attention promptly.